External Validation of the FIRST Trial's Simplified Frailty Score in a Population-based Cohort

Overview

Journal Leukemia

Specialties Hematology
Oncology

Date 2021 Apr 11

PMID 33839738

Citations 6

Authors

Hira S Mian

Smith Giri

Tanya M Wildes

Amaris K Balitsky

Arleigh McCurdy

Gregory R Pond

Branavan Sivapathasundaram

Hsien Seow

Affiliations

Soon will be listed here.

Citing Articles

Isatuximab plus pomalidomide and dexamethasone in frail individuals with relapsed/refractory multiple myeloma in Japan.

Tagami N, Uchiyama M, Suzuki K, Shirai H, Seto T, Iida S Int J Hematol. 2024; .

PMID: 39729222 DOI: 10.1007/s12185-024-03904-y.

A Simple Frailty Score Predicts Survival and Early Mortality in Systemic AL Amyloidosis.

Rios-Tamayo R, Lecumberri R, Cibeira M, Gonzalez-Calle V, Alonso R, Domingo-Gonzalez A Cancers (Basel). 2024; 16(9).

PMID: 38730641 PMC: 11083900. DOI: 10.3390/cancers16091689.

Dynamic frailty risk assessment among older adults with multiple myeloma: A population-based cohort study.

Mian H, Wildes T, Vij R, Pianko M, Major A, Fiala M Blood Cancer J. 2023; 13(1):76.

PMID: 37164972 PMC: 10172354. DOI: 10.1038/s41408-023-00843-5.

Predicting immune-related adverse events using a simplified frailty score in cancer patients treated with checkpoint inhibitors: A retrospective cohort study.

Ladjevardi C, Koliadi A, Ryden V, El-Naggar A, Digkas E, Valachis A Cancer Med. 2023; 12(12):13217-13224.

PMID: 37132258 PMC: 10315811. DOI: 10.1002/cam4.6013.

How I treat multiple myeloma in geriatric patients.

Facon T, Leleu X, Manier S Blood. 2023; 143(3):224-232.

PMID: 36693134 PMC: 10808246. DOI: 10.1182/blood.2022017635.

References

Mian H, Brouwers M, Kouroukis C, Wildes T . Comparison of Frailty Scores in Newly Diagnosed Patients with Multiple Myeloma: A Review. J Frailty Aging. 2019; 8(4):215-221. DOI: 10.14283/jfa.2019.25. View